Important: Help to manage your eye health during the COVID-19 pandemic. Learn more >

Your eyes have more they want to see: EYLEA® (aflibercept) Injection Your eyes have more they want to see: EYLEA® (aflibercept) Injection

Your eyes have more
they want to see.


Discover how EYLEA may be able to help you fight back against certain retinal diseases.

EYLEA is the #1 prescribed treatment in its class FDA-approved for Wet AMD, DME, and MEfRVO.*

*

IBM Truven MarketScan data: Number of injections administered, from Q4 2018 through Q3 2019; Data on File.

Learn about the common symptoms
Diabetic Retinopathy DR

Diabetic Retinopathy (DR)

Diabetic Retinopathy happens when too much blood sugar (glucose) damages the blood vessels in the retina.

See an overview of DR
Diabetic Macular Edema DME

DME

Diabetic Macular Edema is a complication of DR. In DME, the macula swells with fluid leaked from damaged blood vessels in the retina.

See an overview of DME
Wet Age-related Macular Degeneration AMD

Wet AMD

Wet Age-related Macular Degeneration occurs when abnormal blood vessels grow under the macula while also leaking blood and fluid. This damages and scars the macula.

See an overview of Wet AMD
Macular Edema following Retinal Vein Occlusion MEfRVO

MEfRVO

Macular Edema following Retinal Vein Occlusion (MEfRVO) occurs when a blood vessel in the retina becomes blocked by a blood clot and leaks fluid into the macula. Vision loss or blurring happens as the macula swells with the fluid.

See an overview of MEfRVO

DR

Diabetic Retinopathy (DR)

See an overview of DR

DME

Diabetic Macular Edema (DME)

See an overview of DME

WET AMD

Wet Age-related Macular Degeneration (AMD)

See an overview of Wet AMD

MEfRVO

Macular Edema following Retinal Vein Occlusion (MEfRVO)

See an overview of MEfRVO
Helpful resources for people living with low vision and their caregivers.

GET SUPPORT WITH EYLEA.

Whether you're experiencing symptoms for the first time, or are already an EYLEA patient, we have support and resources here for you.

Check out our helpful low vision tips, our resources for caregivers, and our comprehensive support program available to help eligible patients with the cost of EYLEA.

See our helpful resources

SIGN UP FOR MORE INFORMATION

FINANCIAL SUPPORT FROM EYLEA4U®

Sign up to receive information from EYLEA and receive a free pocket magnifier.

Get the latest materials and communications about EYLEA—and a complimentary pocket magnifier, too.

EYLEA4U® logo

EYLEA4U is a comprehensive support program with several resources available to help eligible patients with the cost of EYLEA.

IMPORTANT SAFETY INFORMATION
  • EYLEA® (aflibercept) Injection is a prescription medicine administered by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in EYLEA, including aflibercept.
  • Injections into the eye with EYLEA can result in an infection in the eye and retinal detachment (separation of retina from back of the eye) can occur. Inflammation in the eye has been reported with the use of EYLEA.
  • In some patients, injections with EYLEA may cause a temporary increase in eye pressure within 1 hour of the injection. Sustained increases in eye pressure have been reported with repeated injections, and your doctor may monitor this after each injection.
  • There is a potential but rare risk of serious and sometimes fatal side effects, related to blood clots, leading to heart attack or stroke in patients receiving EYLEA.
  • The most common side effects reported in patients receiving EYLEA were increased redness in the eye, eye pain, cataract, vitreous (gel-like substance) detachment, vitreous floaters, moving spots in the field of vision, and increased pressure in the eye.
  • You may experience temporary visual changes after an EYLEA injection and associated eye exams; do not drive or use machinery until your vision recovers sufficiently.
  • Contact your doctor right away if you think you might be experiencing any side effects, including eye pain or redness, light sensitivity, or blurring of vision, after an injection.
  • For additional safety information, please talk to your doctor and see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

INDICATIONS

EYLEA® (aflibercept) Injection 2 mg (0.05mL) is a prescription medicine approved for the treatment of patients with Wet Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR).

Please see the full Prescribing Information for EYLEA.

The information contained herein is provided for general educational purposes. If you have any questions, talk to your doctor.

For U.S. Residents Only

EYLEA AND EYLEA4U are registered trademarks of Regeneron Pharmaceuticals, Inc.

© 2021, Regeneron Pharmaceuticals, Inc. All rights reserved.
777 Old Saw Mill River Road,
Tarrytown, NY 10591

01/2021
EYL.20.10.0070 EYL.20.10.0070

 

Searching with Lea

Close
MENU